Sr. Investor Relations Manager
About the role
Neurocrine Biosciences is seeking a highly motivated and strategic Senior Investor Relations Manager to support the execution of a best-in-class IR program. This role serves as a key partner to the Vice President of Investor Relations and collaborates closely with senior leadership, Finance, Legal, Commercial, and Corporate Communications to effectively communicate the company’s strategy, financial performance, and pipeline progress to the investment community.
Responsibilities
Partner with the VP of Investor Relations to recommend, develop and execute IR strategy and priorities
Translate business performance, pipeline updates, and corporate strategy into clear, compelling investor narratives
Lead preparation of quarterly earnings materials, including press releases, scripts, presentations, and Q&A
Develop investor presentations, executive briefing materials, and content for investor events
Serve as a primary point of contact for select investors and sell-side analysts
Support and lead execution of investor events, including earnings calls, investor days, conferences, and non-deal roadshows
Ensure consistency, clarity, and strategic alignment across all external communications and disclosures
Partner cross-functionally with Finance, Legal, Commercial, R&D, and Corporate Communications
Influence senior stakeholders to align on messaging, positioning, and disclosure strategy
Analyze investor sentiment, market dynamics, peer performance, competitive landscape and emerging industry trends to inform IR strategy and messaging
Provide actionable insights and recommendations to the VP and senior leadership
Drive continuous improvement of IR processes, tools, and engagement tracking
Ensure compliance with all regulatory and disclosure requirements
Requirements
Bachelor’s degree in Finance, Business, Life Sciences, or related field with 8+ years of relevant experience OR Master’s degree with 6+ years of experience OR Advanced degree (PhD/JD) with 4+ years of experience
Relevant experience in investor relations, equity research, investment banking, corporate communications, or corporate finance strongly preferred
Biotech, pharmaceutical, or healthcare industry experience highly preferred
Strong understanding of capital markets, equity valuation methodologies, institutional investor behavior, and sell-side research processes
Knowledge of SEC disclosure requirements, Regulation FD, and public company investor relations practices
Experience analyzing financial results, market trends, investor sentiment, and competitive dynamics to develop actionable business insights
Ability to interpret and communicate complex clinical, scientific, and regulatory developments into clear investment messaging
Strategic thinker with strong business and financial acumen
Excellent written and verbal communication skills
High level of professionalism and executive presence
Strong analytical and problem-solving capabilities
Collaborative, cross-functional mindset with the ability to influence without authority
Proactive, detail-oriented, and able to manage multiple priorities in a fast-paced environment
High integrity and sound judgment
Pay
The annual base salary we reasonably expect to pay is $148,500.00-$203,000.00. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of role, job duties/requirements, and relevant experience and skills. In addition, this position offers an annual bonus with a target of 30% of the earned base salary and eligibility to participate in our equity based long term incentive program.
Benefits
Retirement savings plan (with company match)
Paid vacation, holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans